Cargando…

Complete Remission of Methotrexate-Related Epstein-Barr-Virus-Associated Hodgkin-Like Lymphoma following Withdrawal of MTX Coupled with Clarithromycin Administration

Patients with rheumatoid arthritis (RA) are known to develop lymphoproliferative disorders (LPDs) during the course of illness, particularly in cases treated with methotrexate (MTX) for long periods. We describe a case of MTX-related Epstein-Barr-virus-(EBV-) associated LPD resembling Hodgkin's...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takemori, Nobuo, Kaneko, Hiroyuki, Nakamura, Masaya, Kojima, Masaru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535817/ https://www.ncbi.nlm.nih.gov/pubmed/23316401 http://dx.doi.org/10.1155/2012/658745

Ejemplares similares

Successful treatment in a case of Propionibacterium acnes-associated sarcoidosis with clarithromycin administration: a case report
por: Takemori, Nobuo, et al.
Publicado: (2014)

Treatment of methotrexate (MTX) intolerance: behavioural therapy, versus switch to parenteral MTX versus oral MTX
por: Verkaaik, M, et al.
Publicado: (2011)

Overexpression of Activation-Induced Cytidine Deaminase in MTX- and Age-Related Epstein-Barr Virus-Associated B-Cell Lymphoproliferative Disorders of the Head and Neck
por: Kikuchi, Kentaro, et al.
Publicado: (2015)

Monoclonal antibody targeting of methotrexate (MTX) against MTX-resistant tumour cell lines.
por: Affleck, K., et al.
Publicado: (1992)

Impairment of Methotrexate (MTX)‐Polyglutamate Formation of MTX‐resistant K562 Cell Lines
por: Koizumi, Shoichi
Publicado: (1988)

A novel combination of bortezomib, lenalidomide, and clarithromycin produced stringent complete response in refractory multiple myeloma complicated with diabetes mellitus – clinical significance and possible mechanisms: a case report
por: Takemori, Nobuo, et al.
Publicado: (2018)

Immune response in LPD during methotrexate administration (MTX-LPD) in rheumatoid arthritis patients
por: Saito, Shuntaro, et al.
Publicado: (2019)

Epstein-Barr virus and the origin of Hodgkin lymphoma
por: Vockerodt, Martina, et al.
Publicado: (2014)

Epstein Barr Virus-Associated Hodgkin Lymphoma
por: Carbone, Antonino, et al.
Publicado: (2018)

Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission
por: Curtis, Jeffrey R., et al.
Publicado: (2021)

Predictors and clinical features of methotrexate (MTX) therapy for ectopic pregnancy
por: Zhang, Jing, et al.
Publicado: (2020)

Evaluation of plasma Epstein–Barr virus DNA as a biomarker for Epstein–Barr virus–associated Hodgkin lymphoma
por: Usha, Masuma Khatun, et al.
Publicado: (2021)

How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?—MTX in the Treat-to-Target Strategy
por: Taylor, Peter. C., et al.
Publicado: (2019)

Methotrexate (MTX) Plus Hydroxychloroquine versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World
por: Zhang, Le, et al.
Publicado: (2020)

Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein–Barr virus infection: a case report and review of the literature
por: Ogawa, Ayumi, et al.
Publicado: (2022)

Rituximab-Induced Remission in Epstein−Barr Virus−Associated Glomerulonephritis
por: Alabdaljabar, Mohamad S., et al.
Publicado: (2020)

Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus(+) Hodgkin's Disease
por: Bollard, Catherine M., et al.
Publicado: (2004)

Molecular Characterisation of Epstein–Barr Virus in Classical Hodgkin Lymphoma
por: Begić, Valerija, et al.
Publicado: (2022)

Monitoring Of High-Dose Methotrexate (Mtx)-Related Toxicity and Mtx Levels in Children with Acute Lymphoblastic Leukemia: A Pilot-Study in Indonesia
por: Sari, Nur Melani, et al.
Publicado: (2021)

LETTER TO THE EDITOR Subcutaneous (SC) Methotrexate (MTX) is Better and Well-Tolerable than Oral MTX in Rheumatoid Arthritis Patients, Switched from Oral to SC Administration Due to Gastrointestinal Side Effects
por: Borman, Pinar, et al.
Publicado: (2014)

Epidemiologic studies assessing the role of the Epstein-Barr virus in Hodgkin's disease.
por: Mueller, N.
Publicado: (1987)

Epstein-Barr virus-associated Hodgkin's disease following renal transplantation
por: Choi, Jung-Hye, et al.
Publicado: (2006)

Chronic Epstein Barr virus infection leading to classical Hodgkin lymphoma
por: Sarwari, Nawid M., et al.
Publicado: (2016)

Downregulation of STAT3 in Epstein-Barr Virus-Positive Hodgkin Lymphoma
por: Nagel, Stefan, et al.
Publicado: (2022)

A case of methotrexate‐associated Epstein‐Barr virus‐positive mucocutaneous ulcer
por: Sakamoto, Keiko, et al.
Publicado: (2022)

Methotrexate (MTX) inhibition of cytokine production: relationship with clinical outcome and genetic polymorphisms
por: Sabina, P, et al.
Publicado: (2003)

Complete remission of aggressive Epstein–Barr virus‐positive diffuse large B‐cell lymphoma following withdrawal of tacrolimus and low‐dose anticancer drugs
por: Obama, Kosuke, et al.
Publicado: (2023)

Uncovering the Role of Epstein–Barr Virus Infection Markers for Remission in Rheumatoid Arthritis
por: Banko, Ana, et al.
Publicado: (2023)

Discussion of Epidemiologic Studies Assessing the Role of the Epstein-Barr Virus in Hodgkin's Disease
por: Grufferman, Seymour
Publicado: (1987)

Contribution of Epstein–Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma
por: Vrzalikova, Katerina, et al.
Publicado: (2018)

Hemophagocytic Lymphohistiocytosis in a Patient with Hodgkin Lymphoma, HIV, and Epstein-Barr Virus
por: Javed, Faiza, et al.
Publicado: (2023)

Possible mechanisms of action of clarithromycin and its clinical application as a repurposing drug for treating multiple myeloma
por: Takemori, Nobuo, et al.
Publicado: (2020)

GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis
por: Vieira-Sousa, Elsa, et al.
Publicado: (2020)

MMP-3 as a predictor for structural remission in RA patients treated with MTX monotherapy
por: Shiozawa, Kazuko, et al.
Publicado: (2016)

A case of classic Hodgkin lymphoma arising after remission of methotrexate-associated follicular lymphoma
por: Ueda, Yayoi, et al.
Publicado: (2023)

Effect of material deprivation on Epstein–Barr virus infection in Hodgkin's disease in the West Midlands
por: Flavell, K, et al.
Publicado: (1999)

Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells
Publicado: (1993)

Epidemiology of Classical Hodgkin Lymphoma and Its Association with Epstein Barr Virus in Northern China
por: Huang, Xin, et al.
Publicado: (2011)

The Role of Epstein-Barr Virus LMP-1 Immunohistochemical Staining in Childhood Hodgkin Lymphoma
por: Tanyildiz, Hikmet Gulsah, et al.
Publicado: (2015)

Hemophagocytic Lymphohistiocytosis Induced by Epstein-Barr Virus Infection and Newly Diagnosed Hodgkin Lymphoma
por: Landry, Ian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9f2tl77hin2is2d8n4uumbrtm9